DGAP-Adhoc: Management Board of CompuGroup Medical SE decides to terminate share buyback program
- 110
DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Share Buyback Key word(s): Share Buyback, Termination Management Board of CompuGroup Medical SE decides to terminate share buyback program Koblenz, October 31, 2019 - The Management Board of CompuGroup Medical SE, Koblenz, ISIN DE0005437305, has decided today to terminate the share buyback program as announced on September 17, 2019 with immediate effect. The total number of shares repurchased by CompuGroup Medical SE under the share buyback program since September 18, 2019 amounts to 415,599. The total number of treasury shares currently held by CompuGroup Medical SE amounts to 4,806,709. This corresponds to 9.03% of all shares in CompuGroup Medical SE. CompuGroup Medical SE Head of Investor Relations CompuGroup Medical SE email: [email protected] phone +49 261 8000 7030 phone +49 261 8000 6200
31-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CompuGroup Medical SE |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)261 8000 6200 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | [email protected] |
Internet: | www.cgm.com |
ISIN: | DE0005437305 |
WKN: | 543730 |
Indices: | MDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 901503 |
End of Announcement | DGAP News Service |
|
901503 31-Oct-2019 CET/CEST
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.